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Evidence for a common progenitor of epithelial and
mesenchymal components of the liver
A Conigliaro1,5, L Amicone1,5, V Costa2, M De Santis Puzzonia1, C Mancone2, B Sacchetti3, C Cicchini1, F Garibaldi1,
DA Brenner4, T Kisseleva4, P Bianco3 and M Tripodi*,1,2
Tissues of the adult organism maintain the homeostasis and respond to injury by means of progenitor/stem cell compartments
capable to give rise to appropriate progeny. In organs composed by histotypes of different embryological origins (e.g. the liver),
the tissue turnover may in theory involve different stem/precursor cells able to respond coordinately to physiological or
pathological stimuli. In the liver, a progenitor cell compartment, giving rise to hepatocytes and cholangiocytes, can be activated by
chronic injury inhibiting hepatocyte proliferation. The precursor compartment guaranteeing turnover of hepatic stellate cells
(HSCs) (perisinusoidal cells implicated with the origin of the liver fibrosis) in adult organ is yet unveiled. We show here that
epithelial and mesenchymal liver cells (hepatocytes and HSCs) may arise from a common progenitor. Scaþ murine progenitor
cells were found to coexpress markers of epithelial and mesenchymal lineages and to give rise, within few generations, to cells
that segregate the lineage-specific markers into two distinct subpopulations. Notably, these progenitor cells, clonally derived,
when transplanted in healthy livers, were found to generate epithelial and mesenchymal liver-specific derivatives (i.e. hepatocytes
and HSCs) properly integrated in the liver architecture. These evidences suggest the existence of a ‘bona fide’ organ-specific
meso-endodermal precursor cell, thus profoundly modifying current models of adult progenitor commitment believed, so far, to be
lineage-restricted. Heterotopic transplantations, which confirm the dual differentiation potentiality of those cells, indicates as
tissue local cues are necessary to drive a full hepatic differentiation. These data provide first evidences for an adult stem/
precursor cell capable to differentiate in both parenchymal and non-parenchymal organ-specific components and candidate the
liver as the instructive site for the reservoir compartment of HSC precursors as yet non-localized in the adult.
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In many postnatal organs, physiological cell turnover and
restoration of cell loss after injury aremaintained by progenitor/
stem cell compartments residing in specialized niches.1–3
Concerning the liver, its ability to regenerate is largely based
on the proliferation of terminally differentiated parenchymal
liver cells (hepatocytes and cholangiocytes); however, when
the proliferation of mature epithelial cells is inhibited by
exposure to drugs or by chronic injury, a progenitor cell
compartment emerges.4,5 These progenitor cells, known as
‘oval cells’ in rodents, and proven to constitute a hetero-
geneous cell population,6 are characterized by the expression
of markers of both cholangiocytes and hepatocytes and by a
high proliferative potential in all species. The progenitors are
regarded as bipotential transient amplifying cells,7,8 down-
stream of a normally quiescent true stem cell. With respect to
the mesenchymal hepatic stellate cells (HSC), while their
embryonic derivation from septum transversum mesenchyme
and from mesothelium has been demonstrated with elegant
experiments of cell lineage tracing,9 their progenitor compart-
ment in the adult liver has not been identified.
HSCs, liver resident cells occupying the space of Disse
between hepatocytes and sinusoids,10–12 have a unique and
critical role in liver physiology and pathology, as they regulate
several functions including storage and release of retinoids
and presentation of lipid antigens to NK cells;13 moreover, in
tissue response to chronic injury, they proliferate and convert
into fibrogenic myofibroblasts leading to fibrosis.14
We previously isolated from murine liver explants and
stabilized in several lines a Sca1þ CD34-, CD45-, albumin-
progenitor cell (RLSC, from resident liver stem cell) capable to
differentiate spontaneously (i.e. without instructive culture
conditions) into hepatocytes.15,16 In this study, we show
the characterization of three different cell lines derived by
cloning procedures from three independent RLSC lines: these
cells coexpress stem, epithelial and mesenchymal markers
and are able to differentiate, in vitro, in subpopulations
expressing either mesenchymal or epithelial genes. Hetero-
topic and orthotopic transplants have been performed in
order to characterize the in vivo differentiation capacity of
RLSCs. Surprisingly, RLSCs transplanted in the growing
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livers of newborn mice, contribute to both mesenchymal
and epithelial hepatic lineages: they in fact differentiate
into hepatocytes and mesenchymal cells that, for their
subendothelial localization together with a GFAP (glial
fibrillary acidic protein) and Desmin positivity, can be
reconducted to HSCs.
Results
RLSCs co-express epithelial and mesenchymal markers
and undergo into mutually exclusive differentiations.
Three RLSC lines, isolated from embryonic livers at 14 days
post coitum (E14/1-1 and E14/3-1) and from liver of a 6-days-
old mouse (NB-D6) and previously characterized for their
broad differentiation capacity,15 have been marked with a
enhanced green fluorescent protein (EGFP)-expressing retro-
virus, seeded at clonal limiting dilution (0.2 cell/well) and
expanded. A single EGFPþ clonal progeny from each of the
starting lines was randomly selected. The results obtained in
cell culture and in vivo experiments and described below were
equivalent for the three clones.
FACS analysis of the undifferentiated RLSC clones revealed
as the cells homogenously express the stem marker SCA1
and notably, coexpress epithelial and mesenchymal markers
such as E-Cadherin, Pan-CK and Vimentin (Figure 1a). An
immunocytochemical analysis confirmed the coexpression of
these proteins (Figure 1b). A broader characterization by FACS
analysis showed that cells were negative for CD144, CD45,
CD90 and Thy1 (data not shown).
Surprisingly, low-serum culture condition gave rise, within
the same culture, to cells with either epithelial or mesench-
ymal morphology (Figure 1c). The unexpected appearance
of two morphologically discrete subpopulations within a
clonal cell line rendered mandatory to gather observations
at single cell level. To this end, we followed single cell
proliferation/differentiation by live imaging. This analysis
allowed to reconduct the dimorphism to single mother cells:
as shown in Figures 1d and e and in the Supplementary
Video, single EGFP-RLSC followed for 5 days gave rise to
cells either coexpressing E-Cadherin and Vimentin or
expressing one of these two markers in a mutually exclusive
fashion.
To further characterize the segregation of epithelial and
mesenchymal markers to different cell populations, a
dimorphic cell culture obtained at confluence after 10 days
of starvation was analysed by immunofluorescence. Staining
for Vimentin/E-Cadherin highlighted as cells express these
markers in a mutually exclusive fashion and in coherence with
the corresponding cellular habit (rare double positive cells are
still detectable). A further analysis for epithelial and mesench-
ymal markers (i.e. HNF4a and aSMA), not expressed in the
starting population, was performed. In line with the previous
observation the epithelial-shaped progeny was found to
acquire the HNF4a expression, while the mesenchymal-
shaped cells were found positive for the myofibroblast-
associate marker a-smooth muscle actin (aSMA); notably,
as expected for lineage-specific markers not present in the
starting population and acquired during differentiation,
no double positive (HNF4a/aSMA) cells were observed
(Figure 2a). Quantitative analysis of markers segregation is
shown in Figure 2b.
These results indicate an intrinsic dual differentiation
potentiality of RLSCs.
RLSC derivatives display liver-specific epithelial and
mesenchymal phenotypes in orthotopic transplant. To
challenge in vivo the intrinsic dual differentiation potentiality
of RLSC, EGFPþ cells were injected directly into the liver of
untreated immuno-tollerant (CD1-nude) mice at the first day
after birth, through a percutaneous trans-abdominal puncture,
according to Bissig et al.17 Animals were killed at various times
and the peak of colonization was found around 2 months after
cell transplantation. RLSC progeny, only capitalizing on the
differentiating and proliferative stimuli of the growing organ
and in competition with endogenous cells, was found to
reproducibly colonize the recipient livers in 40/50 injected
animals. In 30 animals, EGFPþ cells expressing hepatocyte
markers (i.e. the transcription factor HNF4a and Albumin)
engrafted in the hepatocytic muralium with efficiency until
0.01% of total hepatocytes (Figure 3). Notably, in each of the
40 engrafted mice, EGFPþ cells with a mesenchymal shape
and expressing GFAP and Desmin were also observed
(Figure 4a). The subendothelial localization of these cells
(in perisinusoidal spaces, Figure 4b) together with their
immuno-phenotype correspond to those of HSCs.
Taken together, these data indicated that clonal RLSCs
could contribute to both epithelial and mesenchymal specific
compartments of the liver.
RLSCs give rise to liver-specific epithelial and mesench-
ymal derivatives in heterotopic transplants. In order to
determine to what extent the differentiation of transplanted
progenitors into hepatic lineages was induced by liver-
specific local cues, RLSCs were transplanted subcuta-
neously into the back of SCID beige mice, as described
in Materials and Methods. The cotransplants with HUVEC
cells were performed in order to guarantee a homogenous
vascularization inside the implant. Histological and
immunohistochemical analysis of implants showed RLSC
derivatives with both epithelial and mesenchymal phenotypes
(Figure 5a). Although cells bearing an epithelial morphology,
often organized in large ducts mimicking a glandular
organization, were found to express a number of liver
histotype-restricted markers including EpCAM, a-fetoprotein,
E-Cadherin, CK7, Albumin, those displaying a mesenchymal
shape were found to express GFAP and aSMA (Figures 5b
and c). The expression of EpCAM and a-fetoprotein
(endodermal precursor markers), in particular, suggests that
in an extra-hepatic context, RLSC derivatives proliferate
retaining precursor features; moreover, the low expression
of Albumin and CK7 indicates also the RLSCs aptitude to
differentiate toward hepatocytes/cholangiocytes. These
data are extended by RT-PCR and western analysis as
shown in Supplementary Figure 1 (see also Supplementary
Materials and Table 1). With respect to mesenchymal
differentiation, the expression of aSMA and GFAP sug-
gested that the ability of RLSCs to generate an HSC-
like phenotype was also inherent and independent
of exogenous, liver-restricted cues. Overall, heterotopic
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transplantations highlighted that RLSCs retain a binary,
mesenchymal-epithelial potential, independent of soluble
factors, cell-to-cell and cell-to-ECM organ-specific instruc-
tive signals. Taken together these results indicate an
intrinsic dual potential of RLSCs to differentiate into either
epithelial or mesenchymal derivatives. This dual potential,
per se cell-autonomous as reproduced in cell culture, may
harness organ-specific cues in vivo, critical for maturation
toward liver-specific cell types and acquisition of proper tissue
architecture.
Figure 1 RLSC characterization and in vitro differentiation. (a) FACS analysis for the indicated antigens highlighted as the RLSC starting population homogeneously
expresses the stemness marker SCA1, the epithelial markers Pan-CK and E-cad and the mesenchymal marker Vimentin. (b) Immunocytochemical analysis for the indicated
markers highlighted as the RLSC starting population coexpresses epithelial and mesenchymal markers. (c) Within 10 days, RLSCs in low-serum culture condition gave rise to
derivatives that acquired distinct epithelial and mesenchymal phenotypes, as observed by phase contrast (original magnification  20). (d–e) Time-lapse analysis (see also
video 1). Within 5 days single EGFP-RLSC cells, in low-serum culture condition, gave rise to clonal progeny composed of cells coexpressing Vimentin and E-cadherin (yellow
arrows) and cells expressing E-cadherin (blue arrow) or Vimentin (red arrow)
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Figure 2 RLSC derivatives segregation of epithelial and mesenchymal markers into distinct subpopulations. (a) Immunocytochemical analysis for the indicated markers
highlighted as the RLSCs, in low-serum culture condition for 10 days, undergo into either epithelial or mesenchymal differentiation. The morphology of the two different cellular
subpopulations is coherent with the expression of specific markers. (b) Cells were scored in four categories based on their Vimentin and E-Cadherin expression. Data show
percentage of cells for each category. Average of three experiments. N¼ 500 cells were counted for each experiment. Data are shown as mean±S.E.M.
Figure 3 RLSC parenchymal derivatives in orthotopic transplants. Immunohistochemical analysis of RLSC-engrafted livers. The RLSC EGFP progeny was detected in
untreated CD1 null mice injected at day 1 after birth and killed after 2 months. EGFP parenchymal cells were found integrated into the epithelial cords expressing hepatocyte
markers HNF4 and Albumin. Yellow arrows indicate exogenous hepatocytes; white arrows indicate endogenous cells
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Discussion
Taking advance from the RLSC model, we formally proof that
single-cell progeny may undergo into two mutually exclusive
differentiations having as ending point liver-specific mesench-
ymal or epithelial cells (Figure 6, yellow box). Are RLSCs
mimicking events occurring in vivo? Do RLSCs exist in vivo as
stable cell type? While we are not in the position to provide
univocal answer to these questions (see Figure 6, red box, for
conceivable hypothesis), we believe this is not detrimental to
the significance of our data. In fact, despite the limit imposed
by a model based on the utilization of cell lines that could in
theory have acquired ‘non-physiological’ properties, this
approach seems unique in circumventing a major limit of
interpretation of results gathered by means of ‘physiological’
cellular population (e.g. FACS sorted primary cells): whatever
marker utilized for the identification/isolation of precursor cells
may be, in theory, shared by distinct cellular subpopulations
having distinct properties.
The major conceptual advancement coming from this
contribution is due to an unexpected finding: RLSCs, injected
in neonatal healthy growing liver, contribute to the formation of
the adult organ giving derivatives matching anatomical,
morphological and molecular features of both epithelial and
mesenchymal cells. In the mesenchymal progeny character-
ization, both immuno-phenotype and localization of RLSC
derivatives are highly indicative of HSCs. The interesting
evidences that adult liver may instruct a precursor toward
differentiation in HSC should be considered as a self-standing
advance as, as yet, HSC precursors in adult animals have to
be identified.
In recent years, diverse converging evidence based on
in vitro and in vivo experiments utilizing primary or stabilized
liver cells allowed for the identification and characterization of
bipotential precursors able to give rise to hepatocytes and
cholangiocytes.6 These precursor cells (i.e. hepatoblasts in
normal liver development and oval cells in injured adult
organ), as far as we know, give exclusively an epithelial
progeny. Several authors have also suggested the possibility
that HCS themselves can differentiate into hepatocytes;18–21
recent works have demonstrated this in culture22 and in vivo
with a fate-mapping approach,23 thus suggesting that
quiescent HSC could be a component of the progenitor
compartment in adult liver.
The RLSC clonal progeny was found to belong to two
distinct populations that stably maintain their phenotypes in
each of the three environments tested. With respect to the
in vitro differentiation experiments, RLSCs, previously shown
in mitogenic media to differentiate coherently into hepato-
cytes, were found here, when cultured in low serum, to be also
able of accomplishing an alternative mesenchymal differen-
tiation path. The tracking of the initial stages of differentiation
highlighted as RLSCs spontaneously endeavor a mutually
exclusive path that correlate with the loss of stem signature
Figure 4 RLSC non-parenchymal derivatives in orthotopic transplants. Immunohistochemical analysis of RLSC-engrafted livers. The RLSC EGFP progeny was detected
in untreated CD1 null mice injected at day 1 after birth and killed after 2 months. EGFP non-parenchymal cells expressing GFAP and Desmin were found both (a) scattered in
the parenchyma and (b) in subendothelial positions. The endothelium was decorated with CD31 antibody
HSC precursor cells transplantation
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(i.e. SCA1). The segregation of lineage-specific markers
(i.e. E-cadherin and Vimentin) in subpopulations arising from
a bipotent RLSC was strengthened by observations at a
single-cell level by means of live imaging. The copresence of
distinct cellular subpopulations, bearing specific morphology
and observed in the same culture condition, led us to exclude
the hypothesis of a mesenchymal to epithelial or epithelial to
mesenchymal transitions as the driving force of our observa-
tions. Further, dedicated studies may shed light on the
molecular mechanisms influencing self-renewal and/or
mutually exclusive differentiation choices.
With respect to the results obtained from orthotopic
transplantation of RLSCs, notably, both epithelial and
mesenchymal derivatives acquire anatomical localization,
Figure 5 RLSC derivatives in heterotopic transplants. H&E, Immunohistochemical and Immunofluorescence analysis of RLSCs engrafted in SCID adult null mice. RLSCs
were injected in Matrigel in the epifascial region and animals were analyzed 1 month after injection. (a) H&E revealed epithelial-like RLSC derivatives found either arranged in
compact islands or delimiting empty spaces. Mesenchymal-like RLSC derivatives were found scattered in the matrigel scaffold. (b) The EGFP epithelial cells were found to
express the hepatic progenitor/hepatocyte markers, EpCAM, aFP, E-Cad, Albumin and CK7. (c) The EGFP mesenchymal cells were found to express GFAP and aSMA by IF
and IHC (bottom panel)
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morphology and immuno-phenotype of liver-specific
histotypes. We observed that RLSC progeny colonized
non-preconditioned livers of healthy animals (i.e. in competi-
tion with the endogenous compartments) with different
colonization efficiency in relation to different histotypes. In
fact, a limited number of hepatocytes, with respect to a high
and unexpected number of mesenchymal/non-parenchymal
cells, was found. It is conceivable to hypothesize that, in a
growing organ, the stem/precursor compartment contributes
mainly to the expansion of the mesenchymal cells, the
epithelial components being mainly sustained by the pro-
liferation of differentiated hepatocytes/cholangiocytes.
In heterotopic transplants, again, both RLSC mesenchymal
and epithelial derivatives were found: mesenchymal cells
expressed markers shared by HSCs (i.e. GFAP, aSMA);
epithelial derivatives were found mainly aggregated in tubular
structures and expressing markers of endodermal precursors
(i.e. EpCAM, aFP), and only few cells weakly positive for
markers of hepatocytes (i.e. Albumin). This indicates that
in vivo only liver-specific cues allow driving a full liver-specific
differentiation.
Overall, RLSCs can conceivably be proposed as cells
retaining features of the ‘meso-endodermal’ liver progenitor,
whose existence was suggested firstly in chick by Kirby
et al.,24 and then in mouse by Tremblay and Zaret.25
Moreover, we believe that our results evoke those
previously described in three elegant reports,26–28 in which
liver progenitor cells bearing an epithelial-mesenchymal habit
were showed. However, in the characterization of all of those
cells the evidence of a mesenchymal differentiation in vivo is
lacking. Moreover, because the cells described there are not
of clonal origin, a contamination withmesenchymal cells of the
starting cell population was not ruled out. As said, to the best
of our knowledge, this is the first time that a liver progenitor cell
is described in vivo to differentiate toward a lineage with
characteristics attributable to HSCs. On the other hand a
limitation of our approach, as yet, is due to the use of fetal/
newborn-derived cells. Only the formal proof that an RLSC
homolog compartment do exist in vivo and do contribute to
adult liver cells homeostasis will clarify whether RLSC may
contribute to the onset of liver fibrosis and whether the
precursor compartment should be considered an additional
therapeutic target.
Materials and Methods
Cell culture and manipulation. RLSC lines15 were grown in Dulbecco’s
Modified Eagle’s Medium (DMEM) containing 10% FBS (Lonza Group Ltd, Basel,
Switzerland), 2 mmol/l L-glutamine, 100mg/ml penicillin and 100mg/ml strepto-
mycin (Gibco, Grand Island, NY, USA) on collagen I (Transduction Laboratories,
Lexington, UK) coated dishes (Falcon-BD, Franklin Lakes, NJ, USA). RLSCs were
genetically marked by infection with the recombinant PINCO retroviral vector,
which encodes the enhanced EGFP in accordance with Grignani et al.29 and
subcloned by limiting dilution procedure (at a 0 ,2 cell/well dilution).
Animal care and treatment. Animal care and experiments were carried out
according to the criteria outlined in the ‘Guide for the Care and Use of Laboratory
Animals’ of the National Academy of Sciences, published by the National Institutes
of Health (NIH publication 86–23 revised 1985).
In vivo orthotopic transplantation. CD1-nude newborn mice (1 day after
birth) were transplanted by transcutaneous injection into the liver with 1 106
EGFPþRLSCs in 15ml phosphate-buffered saline (PBS) using a 30-gauge
needle (Hamilton Bonaduz AG, Bonaduz, Switzerland). Mice were killed by
cervical dislocation after 30 to 60 days. The livers were removed and dissected;
the specimens were observed under a fluorescent microscope and the colonized
regions were formalin fixed, mounted onto OCT and cooled by liquid nitrogen.
In vivo heterotopic transplantation in growth factors reduced
matrigel. EGFPþRLSCs (1 106) were suspended in 1 ml of growth factors
reduced Matrigel (BD Biosciences Labware, San Diego, CA, USA) with an equal
quantity of HUVEC (Cambrex Corporation, Walkersville, NJ, USA). Aliquots of
about 0 ,7 ml of suspension were injected subcutaneously into the backs of SCID
beige mice (Charles River Laboratories, Raleigh, NC, USA), carefully positioning
the needle between the epidermis and the muscle layer. Mice were killed by
cervical dislocation after 20 days and transplants were immediately fixed for
histology.
Endothelial cells were grown in Clonetics EGM-2 BulletKit (Cambrex Corporation,
Walkersville, NJ, USA) following the manufacturer’s instructions.
Immunofluorescence. Formalin fixed frozen liver tissues were sliced (7 mM)
and stained with: anti-GFP Ab 1/200 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA, sc-8334), anti-EGFP Ab 1/600 (Abnova, Taipei City, Taiwan, MAB1765),
anti-HNF4a Ab 1/100 (Abcam, Cambridge, UK, ab41898), anti-Albumin Ab 1/200
(Novus Biologicals, Cambridge, UK, ab19196), anti-PanCytokeratin Ab 1/500
(Dako, Glostrup, Denmark, z0622), anti-Cytokeratin 7 Ab 1/200 (Abcam, Cambridge,
UK, ab9021), anti-Desmin Ab 1/200 (Thermo Scientific, Fremont, CA, USA,
RB-9014), anti-GFAP Ab 1/200 (Millipore, Billerica, MA, USA, MAB3402), anti-CD31
Ab 1/200 (BD Biosciences, Franklin Lakes, NJ, USA, 55027), anti-EpCAM Ab 1/200
(BD Biosciences 552370), anti-aFetoProtein Ab 1/200 (Santa Cruz Biotechnology
sc-8108), anti-E-Cadherin Ab 1/50 (BD Biosciences 610181) and anti-aSMA Ab
1/200 (Sigma-Aldrich, St Louis, MO, USA, A5228).
Secondary antibodies (Alexa-Fluor 488 and Alexa-Fluor 594 diluted 1/500) were
from Molecular Probes, Eugene, OR, USA. The nuclei were costained with
Figure 6 Schematic representation of hypothetical RLSC origin and of
observed RLSC differentiation capacity. RLSC have been obtained from single-
cell cloning of liver explants. Red box: cells hypothetically giving rise to RLSCs may
include epithelial cells that underwent to EMT during the immortalization procedure,
thus indicating a broad reprogramming potential of parenchymal cells. Alternatively,
an epithelial/mesenchymal RLSC precursor counterpart may exist in vivo. Yellow
box: RLSCs were found in cell culture, in heterotopic and in orthotopic
transplantations, to undergo into two mutually exclusive differentiations having as
ending point mesenchymal or epithelial cells
HSC precursor cells transplantation
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TOPRO3 (Invitrogen, San Diego, CA, USA). Preparations were examined with a
Leica TCS2 confocal microscope.
Immunolocalization was performed using standard immunoperoxidase (DAB
reaction) and counterstained with hematoxylin.
Five micrometers-thick heterotopic transplant sections, embedded in paraffin,
were stained with hematoxylin and eosin. For immunocytochemistry, cells were
grown on collagen I-coated dishes and fixed and treated as previously described.15
Flow cytometry. Cells were suspended in Caþ þ Mgþ þ -free PBS
containing 20% FCS, mouse IgG (40 mg/ml), incubated for 10min on ice and
labeled with fluorochrome-conjugated mAbs for 30min on ice. For intracellular
staining, cells were treated with 10% saponin in PBS. Cell fluorescence was
analysed with the FACS Calibur (Becton Dickinson, Franklin Lakes, NJ, USA).
Antibodies: FITC-conjugated anti-SCA1 (BD Biosciences); Alexa-Fluor 647
Mouse anti-Nestin (BD Biosciences); pan Cytokeratin antibody (C-11) (Phycoer-
ythrin) (ab52460 Abcam); anti-E-Cadherin (CD324) Per-CP-eFluor 710
(e-Bioscence, San Diego, CA, USA); anti-NCadherin C-terminus clone EPR1792Y
(Millipore) and anti-Vimentin Ab (2707-1 Epitomics, Burlingame, CA, USA) both
followed by secondary Alexa-Fluor 596.
Time-lapse video microscopy for clonal assay. A mixed population
of RLSCs and EGFP-expressing RLSCs (ratio of 20 : 1) were seeded on a
collagen-coated micro-dish Grid-500 (Ibidi, Martinsried, Germany, 81166) and
mounted on a micro-incubator stage (OKO Lab, Italy) at 37 1C and 5% CO2 for
time-lapse analysis. Time-lapse video microscopy was performed using a Nikon Ti
Eclipse microscope equipped with a  10 PlanFluor objective starting from a
single GFP positive cell per field. Phase contrast images were acquired every
5min and fluorescent GFP signals were acquired every 60min with a specific
filters set. After 5 days, the grid positions of different clones were annotated and
processed for immunostaining. Cells were fixed with PFA 4% for 10min and
Triton-X100 0 ,1% for 5 min and incubated with different antibodies. Primary
antibodies were: Mouse anti-E-Cadherin (BD Biosciences) and Rabbit anti-
Vimentin (Epitomics). Secondary antibodies were: anti-rabbit AlexaFluor 488
(Invitrogen) and anti-mouse AMCA (Jackson Immunoresearch, Newmarket,
Suffolk, UK). Immunofluorescence analysis was carried out under an Olympus
Vanox microscope equipped with a  40 objective and a SPOT CCD camera
(Diagnostic Instruments, Sterling Heights, MI, USA).
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